Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.

Tobias J, Lebens M, Bölin I, Wiklund G, Svennerholm AM.

Vaccine. 2008 Feb 6;26(6):743-52. doi: 10.1016/j.vaccine.2007.12.009. Epub 2007 Dec 26.

PMID:
18191006
2.

Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.

Tobias J, Svennerholm AM.

Appl Microbiol Biotechnol. 2012 Mar;93(6):2291-300. doi: 10.1007/s00253-012-3930-6. Epub 2012 Feb 16. Review.

PMID:
22350259
3.

From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.

Svennerholm AM.

Indian J Med Res. 2011 Feb;133:188-96. Review.

5.

A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression.

Isidean SD, Riddle MS, Savarino SJ, Porter CK.

Vaccine. 2011 Aug 26;29(37):6167-78. doi: 10.1016/j.vaccine.2011.06.084. Epub 2011 Jul 1. Review.

PMID:
21723899
6.

Vaccines for enterotoxigenic Escherichia coli: current status.

Boedeker EC.

Curr Opin Gastroenterol. 2005 Jan;21(1):15-9. Review.

PMID:
15687879
7.

Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease.

Walker RI, Steele D, Aguado T; Ad Hoc ETEC Technical Expert Committee.

Vaccine. 2007 Mar 30;25(14):2545-66. Epub 2006 Dec 19. Review.

PMID:
17224212
8.

Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals.

Moon HW, Bunn TO.

Vaccine. 1993;11(2):213-200. Review.

PMID:
8094931
9.

Progress towards a vaccine against enterotoxigenic Escherichia coli.

Kaper JB, Levine MM.

Vaccine. 1988 Apr;6(2):197-9. Review.

PMID:
2898844
10.

Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.

Buddenborg C, Daudel D, Liebrecht S, Greune L, Humberg V, Schmidt MA.

Int J Med Microbiol. 2008 Jan;298(1-2):105-14. Epub 2007 Oct 23. Review.

PMID:
17936683
11.

Vaccines against enterotoxigenic Escherichia coli.

Svennerholm AM, Tobias J.

Expert Rev Vaccines. 2008 Aug;7(6):795-804. doi: 10.1586/14760584.7.6.795. Review.

PMID:
18665777
12.

Enterotoxigenic Escherichia coli virulence factors and vaccine approaches.

Sizemore DR, Roland KL, Ryan US.

Expert Rev Vaccines. 2004 Oct;3(5):585-95. Review.

PMID:
15485338
14.

Colonization factors of human enterotoxigenic Escherichia coli (ETEC).

Gaastra W, Svennerholm AM.

Trends Microbiol. 1996 Nov;4(11):444-52. Review.

PMID:
8950814
15.

Safe, live Vibrio cholerae vaccines?

Taylor R, Shaw C, Peterson K, Spears P, Mekalanos J.

Vaccine. 1988 Apr;6(2):151-4. Review.

PMID:
2898843
16.

Fimbrial adhesions of Escherichia coli.

Klemm P.

Rev Infect Dis. 1985 May-Jun;7(3):321-40. Review.

PMID:
2862689
17.

Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains.

Gaastra W, de Graaf FK.

Microbiol Rev. 1982 Jun;46(2):129-61. Review. No abstract available.

18.

New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Levine MM, Kaper JB, Black RE, Clements ML.

Microbiol Rev. 1983 Dec;47(4):510-50. Review.

19.

New vaccine strategies against enterotoxigenic Escherichia coli. I: DNA vaccines against the CFA/I fimbrial adhesin.

Alves AM, Lásaro MO, Almeida DF, Ferreira LC.

Braz J Med Biol Res. 1999 Feb;32(2):223-9. Review.

PMID:
10347758

Supplemental Content

Support Center